Clinical Trial Update: Neuronavigation Guided iTBS With Personalized Target for Depression [Phase 2]

View source ↗

Summary

Phase 2 study update on neuronavigation-guided intermittent theta-burst stimulation with a personalized target for depression, sponsored by Xijing Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Xijing Hospital | Conditions: Depression | Phase 2 | Status: UNKNOWN